NCT03324399View on ClinicalTrials.gov

A Study of Protein Metabolism, Microbiome and Investigational Probiotic Use in Patients With ALS

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

June 26, 2019

Study Completion Date

June 26, 2019

Conditions
Amyotrophic Lateral SclerosisALS
Interventions
DIETARY_SUPPLEMENT

probiotic

a proprietary probiotic formulation

Trial Locations (1)

57105

Avera Medical Group Palliative Medicine Sioux Falls, Sioux Falls

All Listed Sponsors
lead

Avera McKennan Hospital & University Health Center

OTHER

NCT03324399 - A Study of Protein Metabolism, Microbiome and Investigational Probiotic Use in Patients With ALS | Biotech Hunter | Biotech Hunter